首页 | 本学科首页   官方微博 | 高级检索  
     

经药盒系统对晚期肿瘤行化疗栓塞的临床研究
引用本文:赵继红,杨海山,王大伟. 经药盒系统对晚期肿瘤行化疗栓塞的临床研究[J]. 中国肿瘤临床, 2002, 29(1): 9-11
作者姓名:赵继红  杨海山  王大伟
作者单位:吉林大学中日联祖医院放射科,长春市,130031
基金项目:吉林省科技发展项目基金资助(编号:990571-2)
摘    要:目的:采用介入技术经锁骨下动脉入路皮下植入药盒系统。研究经药盒系统对晚期肿瘤行化疗栓塞的临床疗效。方法:随机分成A、B两组。A组选择化疗栓塞的给药方案,B组选择单纯灌注化疗的给药方案,各20例。结果:两组有效率(CR+PR)A组为45%,B组为20%(P<0.05)。1年生存率A组为50%,B组为30%(P<0.05)。结论:晚期肝癌患者,采用介入技术经锁骨下动脉入路皮下植入药盒系统行化疗栓塞是有效、可行的。

关 键 词:肝癌 植入药盒 放射学 介入治疗 化疗 晚期肿瘤
文章编号:1000-8179(2002)01-0009-03

Clinical Evaluation of Therapeutic Effect to Hepatic Malignant Tumors by Implantable Drug Delivery System
Zhao Jihong Yang Haishan Wang Dawei. Clinical Evaluation of Therapeutic Effect to Hepatic Malignant Tumors by Implantable Drug Delivery System[J]. Chinese Journal of Clinical Oncology, 2002, 29(1): 9-11
Authors:Zhao Jihong Yang Haishan Wang Dawei
Affiliation:Zhao Jihong Yang Haishan Wang Dawei Department of Radiology,Sino-Japanese Friendship Hospital,Jilin
Abstract:Objective:The aim of this study is to evaluate the therapeutic effect to hepatic malignant tumors by implantable drug delivery system(DDS)via subclavian artery.Methods:Forty patients were randomly divided into two groups;Group A(20cases)were treated by TAE.Group B(20cases)were treated by TAI.Results:The response rate(CR+PR)was45%for Group A and20%for Group B(P<0.05),and the1-year survival rates of Group A and Group B were50%and30%respectively(P<0.05).Conclusion:The interventional technology is feasible and effective in the treatment of hepatic malignant tumors by TAE through DDS.
Keywords:Hepatic malignant tumor Interventional therapy Implantable drug delivery system Radiology
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号